Experiment number | Donor/source strain for bacteriophage | Growth condition (in DMEM Medium) | Bacterio-phage titer | Fold reduction by zinc |
---|---|---|---|---|
Expt. 1 | TSA14; O26:H11, Stx1+; harbors phage H19B | control, no additives | 1:10 | Â |
+ 0.4Â mM Zn | no plaques, < 1:10 | > 2-fold decrease | ||
+ 4Â ng/ml cipro | 1:640 | |||
+ 4 cipro + 0.4 mM Zn | 1:80 | 8-fold decrease | ||
Expt. 2 | TSA14; O26:H11 | control, no additives | 1:20 | Â |
+ 0.6Â mM Zn | no plaques | > 2-fold decrease | ||
+ 8Â ng/ml cipro | 1:640 | Â | ||
+ 8 cipro + 0.4 mM Zn | 1:160 | 4-fold decrease | ||
+ 8 cipro + 0.6 mM Zn | 1:80 | 8-fold decrease | ||
Expt. 3 | EDL933; O157:H7; Stx1+, Stx2+; | control | 1:80 | Â |
+ 0.6Â mM Zn | 1:40 | 2-fold decrease | ||
Harbors phages H19B and 933Â W | + 10Â ng/ml cipro | > 1:5120 | Â | |
+ 10 cipro + 0.6 mM Zn | 1:320 | ≥ 16-fold decrease | ||
Expt. 4 | EDL933 | control | 1:80 | Â |
+ 0.6Â mM Zn | 1:20 | 4-fold decrease | ||
+ 10Â ng/ml cipro | 1:640 | Â | ||
+ 10 cipro + 0.6 mM Zn | 1:160 | 4-fold decrease |